AIXC - Qualigen Therapeutics, Inc.
1.1
0.020 1.818%
Share volume: 21,102
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.08
0.02
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 07-02-2024 | 08-14-2024 | 11-14-2024 | 08-14-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 1.003 M | 534.410 K | 2.313 M | 3.963 M | 43.470 M | |
| Current Assets | 1.003 M | 534.410 K | 2.313 M | 3.961 M | 43.468 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 93.217 K | 118.685 K | 388.152 K | 331.601 K | 38.777 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 2.000 K | 2.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 1.003 M | 534.410 K | 2.313 M | 3.963 M | 43.470 M | |
| Total liabilities | 4.525 M | 4.812 M | 4.454 M | 5.615 M | 4.923 M | |
| Total current liabilities | 4.525 M | 4.812 M | 4.454 M | 5.615 M | 4.923 M | |
| Accounts Payable | 1.801 M | 1.854 M | 1.638 M | 1.405 M | 1.282 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -3.522 M | -4.278 M | -2.141 M | -4.442 M | 2.447 M | |
| Common stock | 115.313 M | 116.134 M | 120.065 M | 122.951 M | 131.878 M | |
| Retained earnings | -118.835 M | -120.412 M | -122.206 M | -127.393 M | -129.431 M |